Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT)

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Pulmonary Hypertension · Rheumatic Valvular Heart Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sindh Institute of Cardiovascular Diseases, Hyderābād, Sindh, Pakistan
Contact: Study coordinator (Dr Aamir Khuwaja) · 03323594539

Study leads

Dr Jawaid Akbar Sial
Study Director
Sindh Institute of Cardiovascular Diseases

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Pulmonary Hypertension

Abroad (travel likely)RecruitingPHASE3

Tucson, United States · La Jolla, United States

Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD

Group 3 Pulmonary Hypertension

Abroad (travel likely)RecruitingPHASE2

Hualien City, Taiwan · Kaohsiung City, Taiwan

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

Pulmonary Hypertension · Heart Failure With Reduced Ejection Fraction · Hypertension

Abroad (travel likely)RecruitingPHASE3

Shenyang, China

Chronic Thromboembolic Disease Registry

Chronic Thromboembolic Pulmonary Hypertension · Chronic Thromboembolic Disease

Abroad (travel likely)Recruiting

San Francisco, United States